Cargando…

Recurrent novel HMGA2-NCOR2 fusions characterize a subset of keratin-positive giant cell-rich soft tissue tumors

Giant cell tumors of soft tissue (GCT-ST) are rare low-grade neoplasms that were at one time thought to represent the soft tissue counterparts of GCT of bone (GCT-B) but are now known to lack the H3F3 mutations characteristic of osseous GCT. We present six distinctive giant cell-rich soft tissue neo...

Descripción completa

Detalles Bibliográficos
Autores principales: Agaimy, Abbas, Michal, Michael, Stoehr, Robert, Ferrazzi, Fulvia, Fabian, Pavel, Michal, Michal, Franchi, Alessandro, Haller, Florian, Folpe, Andrew L., Kösemehmetoğlu, Kemal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295036/
https://www.ncbi.nlm.nih.gov/pubmed/33742141
http://dx.doi.org/10.1038/s41379-021-00789-8
_version_ 1783725357846757376
author Agaimy, Abbas
Michal, Michael
Stoehr, Robert
Ferrazzi, Fulvia
Fabian, Pavel
Michal, Michal
Franchi, Alessandro
Haller, Florian
Folpe, Andrew L.
Kösemehmetoğlu, Kemal
author_facet Agaimy, Abbas
Michal, Michael
Stoehr, Robert
Ferrazzi, Fulvia
Fabian, Pavel
Michal, Michal
Franchi, Alessandro
Haller, Florian
Folpe, Andrew L.
Kösemehmetoğlu, Kemal
author_sort Agaimy, Abbas
collection PubMed
description Giant cell tumors of soft tissue (GCT-ST) are rare low-grade neoplasms that were at one time thought to represent the soft tissue counterparts of GCT of bone (GCT-B) but are now known to lack the H3F3 mutations characteristic of osseous GCT. We present six distinctive giant cell-rich soft tissue neoplasms that expressed keratins and carried a recurrent HMGA2-NCOR2 gene fusion. Patients were five females and one male aged 14–60 years (median, 29). All presented with superficial (subcutaneous) masses that were removed by conservative marginal (3) or wide (2) local excision. The tumors originated in the upper extremity (2), lower extremity (2), head/neck (1), and trunk (1). Five patients with follow-up (median, 21 months; range, 14–168) remained disease-free. Grossly, all tumors were well-demarcated but not encapsulated with variable lobulation. Histologically, they were composed of bland plump epithelioid or ovoid to spindled mononuclear cells admixed with evenly distributed multinucleated osteoclast-type giant cells. Foci of stromal hemorrhage and hemosiderin were seen in all cases. The mitotic activity ranged from 2 to 14/10 high power fields (median: 10). Foci of necrosis and vascular invasion were seen in one case each. The mononuclear cells were immunoreactive with the AE1/AE3 keratin cocktail and less frequently/less diffusely for K7 and K19 but lacked expression of other lineage-associated markers. RNA-based next-generation sequencing revealed an HMGA2-NCOR2 fusion in all tumors. None of the keratin-negative conventional GCT-ST showed the HMGA2-NCOR2 fusion (0/7). Metaplastic bone (4/9) and SATB2 expression (3/4) were frequent in keratin-negative conventional GCT-ST but were lacking in keratin-positive HMGA2-NCOR2 fusion-positive tumors. The distinctive immunophenotype and genotype of these tumors strongly suggest that they represent a discrete entity, differing from conventional GCT-ST and other osteoclast-rich morphologic mimics. Their natural history appears favorable, although a study of additional cases and longer follow-up are warranted.
format Online
Article
Text
id pubmed-8295036
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group US
record_format MEDLINE/PubMed
spelling pubmed-82950362021-08-05 Recurrent novel HMGA2-NCOR2 fusions characterize a subset of keratin-positive giant cell-rich soft tissue tumors Agaimy, Abbas Michal, Michael Stoehr, Robert Ferrazzi, Fulvia Fabian, Pavel Michal, Michal Franchi, Alessandro Haller, Florian Folpe, Andrew L. Kösemehmetoğlu, Kemal Mod Pathol Article Giant cell tumors of soft tissue (GCT-ST) are rare low-grade neoplasms that were at one time thought to represent the soft tissue counterparts of GCT of bone (GCT-B) but are now known to lack the H3F3 mutations characteristic of osseous GCT. We present six distinctive giant cell-rich soft tissue neoplasms that expressed keratins and carried a recurrent HMGA2-NCOR2 gene fusion. Patients were five females and one male aged 14–60 years (median, 29). All presented with superficial (subcutaneous) masses that were removed by conservative marginal (3) or wide (2) local excision. The tumors originated in the upper extremity (2), lower extremity (2), head/neck (1), and trunk (1). Five patients with follow-up (median, 21 months; range, 14–168) remained disease-free. Grossly, all tumors were well-demarcated but not encapsulated with variable lobulation. Histologically, they were composed of bland plump epithelioid or ovoid to spindled mononuclear cells admixed with evenly distributed multinucleated osteoclast-type giant cells. Foci of stromal hemorrhage and hemosiderin were seen in all cases. The mitotic activity ranged from 2 to 14/10 high power fields (median: 10). Foci of necrosis and vascular invasion were seen in one case each. The mononuclear cells were immunoreactive with the AE1/AE3 keratin cocktail and less frequently/less diffusely for K7 and K19 but lacked expression of other lineage-associated markers. RNA-based next-generation sequencing revealed an HMGA2-NCOR2 fusion in all tumors. None of the keratin-negative conventional GCT-ST showed the HMGA2-NCOR2 fusion (0/7). Metaplastic bone (4/9) and SATB2 expression (3/4) were frequent in keratin-negative conventional GCT-ST but were lacking in keratin-positive HMGA2-NCOR2 fusion-positive tumors. The distinctive immunophenotype and genotype of these tumors strongly suggest that they represent a discrete entity, differing from conventional GCT-ST and other osteoclast-rich morphologic mimics. Their natural history appears favorable, although a study of additional cases and longer follow-up are warranted. Nature Publishing Group US 2021-03-19 2021 /pmc/articles/PMC8295036/ /pubmed/33742141 http://dx.doi.org/10.1038/s41379-021-00789-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Agaimy, Abbas
Michal, Michael
Stoehr, Robert
Ferrazzi, Fulvia
Fabian, Pavel
Michal, Michal
Franchi, Alessandro
Haller, Florian
Folpe, Andrew L.
Kösemehmetoğlu, Kemal
Recurrent novel HMGA2-NCOR2 fusions characterize a subset of keratin-positive giant cell-rich soft tissue tumors
title Recurrent novel HMGA2-NCOR2 fusions characterize a subset of keratin-positive giant cell-rich soft tissue tumors
title_full Recurrent novel HMGA2-NCOR2 fusions characterize a subset of keratin-positive giant cell-rich soft tissue tumors
title_fullStr Recurrent novel HMGA2-NCOR2 fusions characterize a subset of keratin-positive giant cell-rich soft tissue tumors
title_full_unstemmed Recurrent novel HMGA2-NCOR2 fusions characterize a subset of keratin-positive giant cell-rich soft tissue tumors
title_short Recurrent novel HMGA2-NCOR2 fusions characterize a subset of keratin-positive giant cell-rich soft tissue tumors
title_sort recurrent novel hmga2-ncor2 fusions characterize a subset of keratin-positive giant cell-rich soft tissue tumors
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295036/
https://www.ncbi.nlm.nih.gov/pubmed/33742141
http://dx.doi.org/10.1038/s41379-021-00789-8
work_keys_str_mv AT agaimyabbas recurrentnovelhmga2ncor2fusionscharacterizeasubsetofkeratinpositivegiantcellrichsofttissuetumors
AT michalmichael recurrentnovelhmga2ncor2fusionscharacterizeasubsetofkeratinpositivegiantcellrichsofttissuetumors
AT stoehrrobert recurrentnovelhmga2ncor2fusionscharacterizeasubsetofkeratinpositivegiantcellrichsofttissuetumors
AT ferrazzifulvia recurrentnovelhmga2ncor2fusionscharacterizeasubsetofkeratinpositivegiantcellrichsofttissuetumors
AT fabianpavel recurrentnovelhmga2ncor2fusionscharacterizeasubsetofkeratinpositivegiantcellrichsofttissuetumors
AT michalmichal recurrentnovelhmga2ncor2fusionscharacterizeasubsetofkeratinpositivegiantcellrichsofttissuetumors
AT franchialessandro recurrentnovelhmga2ncor2fusionscharacterizeasubsetofkeratinpositivegiantcellrichsofttissuetumors
AT hallerflorian recurrentnovelhmga2ncor2fusionscharacterizeasubsetofkeratinpositivegiantcellrichsofttissuetumors
AT folpeandrewl recurrentnovelhmga2ncor2fusionscharacterizeasubsetofkeratinpositivegiantcellrichsofttissuetumors
AT kosemehmetoglukemal recurrentnovelhmga2ncor2fusionscharacterizeasubsetofkeratinpositivegiantcellrichsofttissuetumors